Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia. | Haematologica | 2021 | 33730844 | PubTator, text mining | PubMed |
| Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant. | Onco Targets Ther | 2021 | 33727830 | PubTator, text mining | PubMed |
| Managing chronic lymphocytic leukemia in 2020: an update on recent clinical advances with a focus on BTK and BCL-2 inhibitors. | Fac Rev | 2021 | 33718939 | PubTator, text mining | PubMed |
| The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action. | Blood Cancer J | 2021 | 33714981 | PubTator, text mining | PubMed |
| A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation. | Cancer Cell | 2021 | 33689703 | PubTator, text mining | PubMed |
| Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia. | Drug Des Devel Ther | 2021 | 33688166 | PubTator, text mining | PubMed |
| Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins. | Immunity | 2021 | 33675683 | PubTator, text mining | PubMed |
| A Newly Assigned Role of CTCF in Cellular Response to Broken DNAs. | Biomolecules | 2021 | 33673494 | PubTator, text mining | PubMed |
| Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients. | J Clin Med | 2021 | 33669782 | PubTator, text mining | PubMed |
| Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol. | Eur J Haematol | 2021 | 33662164 | PubTator, text mining | PubMed |
| A 3' tRNA-derived fragment produced by tRNALeuAAG and tRNALeuTAG is associated with poor prognosis in B-cell chronic lymphocytic leukemia, independently of classical prognostic factors. | Eur J Haematol | 2021 | 33660275 | PubTator, text mining | PubMed |
| Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study. | Leuk Lymphoma | 2021 | 33653216 | PubTator, text mining | PubMed |
| Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. | Blood | 2021 | 33651883 | PubTator, text mining | PubMed |
| Validating genomic tools for precision medicine in chronic lymphocytic leukemia: ERIC leads the way. | Haematologica | 2021 | 33645943 | PubTator, text mining | PubMed |
| Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia. | Clin Transl Med | 2021 | 33634999 | PubTator, text mining | PubMed |
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group. | Br J Haematol | 2021 | 33618437 | PubTator, text mining | PubMed |
| Convergent antibody evolution and clonotype expansion following influenza virus vaccination. | PLoS One | 2021 | 33617543 | PubTator, text mining | PubMed |
| Minimal Residual Disease in Chronic Lymphocytic Leukemia: Highlights From SOHO 2020. | J Adv Pract Oncol | 2021 | 33614186 | PubTator, text mining | PubMed |
| The role of acalabrutinib in adults with chronic lymphocytic leukemia. | Ther Adv Hematol | 2021 | 33613932 | PubTator, text mining | PubMed |
| Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy. | Blood Cancer Discov | 2021 | 33604581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=49